Clinically relevant outcomes measures in major depressive disorder

被引：0
|
作者：
Montgomery, S. [1 ]
机构：
[1] Imperial Coll Sch Med, London, England
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2008年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：318 / 318
页数：1
相关论文
共 50 条
  • [1] Anxious depression as a clinically relevant subtype of pediatric major depressive disorder
    Isabelle Häberling
    Noemi Baumgartner
    Sophie Emery
    Paola Keller
    Michael Strumberger
    Kristin Nalani
    Klaus Schmeck
    Suzanne Erb
    Silke Bachmann
    Lars Wöckel
    Ulrich Müller-Knapp
    Brigitte Contin-Waldvogel
    Bruno Rhiner
    Susanne Walitza
    Gregor Berger
    [J]. Journal of Neural Transmission, 2019, 126 : 1217 - 1230
  • [2] Anxious depression as a clinically relevant subtype of pediatric major depressive disorder
    Haeberling, Isabelle
    Baumgartner, Noemi
    Emery, Sophie
    Keller, Paola
    Strumberger, Michael
    Nalani, Kristin
    Schmeck, Klaus
    Erb, Suzanne
    Bachmann, Silke
    Woeckel, Lars
    Mueller-Knapp, Ulrich
    Contin-Waldvogel, Brigitte
    Rhiner, Bruno
    Walitza, Susanne
    Berger, Gregor
    [J]. JOURNAL OF NEURAL TRANSMISSION, 2019, 126 (09) : 1217 - 1230
  • [3] Anxious depression as a clinically relevant subtype of pediatric major depressive disorder.
    Haberling, I.
    Baumgartner, N.
    Emery, S.
    Keller, P.
    Strumberger, M.
    Nalani, K.
    Schmeck, K.
    Erb, S.
    Bachmann, S.
    Wockel, L.
    Muller-Knapp, U.
    Contin, B.
    Rhiner, B.
    Walitza, S.
    Berger, G.
    [J]. JOURNAL OF NEURAL TRANSMISSION, 2019, 126 (11) : 1532 - 1532
  • [4] Clinically relevant real-world predictors of hospitalization in patients with major depressive disorder
    Croteau, Nicole
    Patel, Rashmi
    Poritz, Julia
    Simeone, Jason
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 226 - 227
  • [5] Neuromodulation for major depressive disorder: innovative measures to capture efficacy and outcomes
    Rabin, Jennifer S.
    Davidson, Benjamin
    Giacobbe, Peter
    Hamani, Clement
    Cohn, Melanie
    Illes, Judy
    Lipsman, Nir
    [J]. LANCET PSYCHIATRY, 2020, 7 (12): : 1075 - 1080
  • [6] Altered ability to access a clinically relevant control network in patients remitted from major depressive disorder
    Figueroa, Caroline A.
    Cabral, Joana
    Mocking, Roel J. T.
    Rapuano, Kristina M.
    van Hartevelt, Tim J.
    Deco, Gustavo
    Expert, Paul
    Schene, Aart H.
    Kringelbach, Morten L.
    Ruhe, Henricus G.
    [J]. HUMAN BRAIN MAPPING, 2019, 40 (09) : 2771 - 2786
  • [7] Identifying Clinically Relevant Electroencephalography Coherence Patterns in Major Depressive Disorder: Results from the EMBARC Study
    Cooper, Crystal
    Fatt, Cherise Chin
    Delarosa, Bambi
    Grannerman, Bruce
    Fava, Maurizio
    Kurian, Benji
    McGrath, Patrick
    McInnis, Melvin
    Parsey, Ramin
    Weissman, Myrna
    Bruder, Gerard
    Tenke, Craig
    Hart, John
    Trivedi, Madhukar
    [J]. BIOLOGICAL PSYCHIATRY, 2017, 81 (10) : S380 - S380
  • [8] WHAT IS THE THRESHOLD FOR A CLINICALLY RELEVANT EFFECT? THE CASE OF MAJOR DEPRESSIVE DISORDERS
    Cuijpers, Pim
    Turner, Erick H.
    Koole, Sander L.
    van Dijke, Annemiek
    Smit, Filip
    [J]. DEPRESSION AND ANXIETY, 2014, 31 (05) : 374 - 378
  • [9] CLINICALLY RELEVANT MEASURES
    DAY, SJ
    [J]. CONTROLLED CLINICAL TRIALS, 1994, 15 (04): : 328 - 328
  • [10] Prediction of treatment outcomes in major depressive disorder
    Dunlop, Boadie W.
    [J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2015, 8 (06) : 669 - 672
12345